Search
元素の検索
構造の検索
Thermo Scientific Chemicals
Pyruvic aldehyde, 35-45% w/w aq. soln
CAS: 78-98-8 | C3H4O2 | 72.06 g/mol
化学物質識別子
CAS78-98-8
IUPAC Name2-oxopropanal
Molecular FormulaC3H4O2
InChI KeyAIJULSRZWUXGPQ-UHFFFAOYSA-N
SMILESCC(=O)C=O
さらに表示
仕様
スペックシート
スペックシートAppearance (Color)Clear colorless to yellow to orange
Acid-base back titration28-50%
CommentRI variable with level of polymerisation
Refractive Index1.3910-1.4200 @ 20°C
FormLiquid
Pyruvic aldehyde is used in the synthesis and cytotoxicity evaluation of N-terminal analogues of tubulysin-U an antimitotic compound. Also used in the synthesis of imidazoles as potent calcitonin gene-related CGRP antagonists.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
Pyruvic aldehyde is used in the synthesis and cytotoxicity evaluation of N-terminal analogues of tubulysin-U an antimitotic compound. Also used in the synthesis of imidazoles as potent calcitonin gene-related CGRP antagonists.
Solubility
Soluble in DMSO, water.
Notes
Air sensitive. Store under dry inert gas. Store away from oxidizing agents, air.
Pyruvic aldehyde is used in the synthesis and cytotoxicity evaluation of N-terminal analogues of tubulysin-U an antimitotic compound. Also used in the synthesis of imidazoles as potent calcitonin gene-related CGRP antagonists.
Solubility
Soluble in DMSO, water.
Notes
Air sensitive. Store under dry inert gas. Store away from oxidizing agents, air.
RUO – Research Use Only
General References:
- Paul J Beisswenger; Keith S Drummond; Robert G Nelson; Scott K Howell; Benjamin S Szwergold; Michael Mauer. Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes. 2005, 54 (11), 3274-3281.
- Katrien H J Gaens; Coen D A Stehouwer; Casper G Schalkwijk. Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Current Opinion in Lipidology. 2013, 24 (1), 4-11.